Search Results

Filter
  • 1-10 of  242 results for ""Sitagliptin Phosphate""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia.

  • Authors : Harris DD; Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, United States of America.; Sabe SA

Subjects: Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/pharmacology ; Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/therapeutic use ; Fibrosis*

  • Source: PloS one [PLoS One] 2024 Jul 29; Vol. 19 (7), pp. e0307922. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy.

  • Authors : Kuo CS; Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2024 Sep; Vol. 215, pp. 111814. Date of Electronic Publication: 2024 Aug 08.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test.

  • Authors : Beitelshees AL; Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Streeten EA

Subjects: Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/pharmacology ; Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/administration & dosage ; Glucose Tolerance Test*

  • Source: Clinical and translational science [Clin Transl Sci] 2024 May; Vol. 17 (5), pp. e13809.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial.

  • Authors : Yang L; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.; Liang H

Subjects: Insulin Resistance*; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*physiopathology

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Mar 25; Vol. 106 (4), pp. e1529-e1541.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes.

  • Authors : Shankar RR; Merck & Co., Inc., Kenilworth, New Jersey, USA.; Bao Y

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin/Insulin/Insulin/*therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2017 May; Vol. 8 (3), pp. 321-329. Date of Electronic Publication: 2016 Dec 09.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

×
Academic Journal

Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.

  • Authors : Yu M; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital; Chinese Academy of Medical Sciences, Beijing, China.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Insulin/Insulin/Insulin/*administration & dosage

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Feb; Vol. 21 (2), pp. 408-411. Date of Electronic Publication: 2018 Oct 03.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2019 Mar; Vol. 10 (2), pp. 383-391. Date of Electronic Publication: 2018 Sep 25.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

×
Academic Journal

[Clinical observation on the combined therapy of sitagliptin with insulin for patients with brittle diabetes].

  • Authors : Luo N; Department of Endocrinology, Subei People's Hospital, Yangzhou Jiangsu 225000, China.; Zhu Y

Subjects: Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage ; Insulin/Insulin/Insulin/*administration & dosage

  • Source: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences [Zhong Nan Da Xue Xue Bao Yi Xue Ban] 2015 Oct; Vol. 40 (10), pp. 1089-95.Publisher:

Record details

×
Academic Journal

Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.

  • Authors : Sato S; Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.; Saisho Y

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage ; Insulin/Insulin/Insulin/*administration & dosage

  • Source: PloS one [PLoS One] 2015 Mar 27; Vol. 10 (3), pp. e0121988. Date of Electronic Publication: 2015 Mar 27 (Print Publication: 2015).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  242 results for ""Sitagliptin Phosphate""